Potential Functional Role of Phenethylamine Derivatives in Inhibiting Dopamine Reuptake: Structure-Activity Relationship.

Docking simulation Dopamine D Dopamine transporter Drug addiction Phenethylamine Structure activity relationship

Journal

Biomolecules & therapeutics
ISSN: 1976-9148
Titre abrégé: Biomol Ther (Seoul)
Pays: Korea (South)
ID NLM: 101472832

Informations de publication

Date de publication:
01 Jan 2023
Historique:
received: 10 04 2022
revised: 25 07 2022
accepted: 03 08 2022
pubmed: 14 9 2022
medline: 14 9 2022
entrez: 13 9 2022
Statut: ppublish

Résumé

Numerous psychotropic and addictive substances possess structural features similar to those of β-phenethylamine (β-PEA). In this study, we selected 29 β-PEA derivatives and determined their structure-activity relationship (SAR) to their ability to inhibit dopamine (DA) reuptake; conducted docking simulation for two selected compounds; and identified their potential functionals. The compounds were subdivided into arylethylamines, 2-(alkyl amino)-1-arylalkan-1-one derivatives and alkyl 2-phenyl-2-(piperidin-2-yl)acetate derivatives. An aromatic group, alkyl group, and alkylamine derivative were attached to the arylethylamine and 2-(alkyl amino)-1-arylalkan-1-one derivatives. The inhibitory effect of the compounds on dopamine reuptake increased in the order of the compounds substituted with phenyl, thiophenyl, and substituted phenyl groups in the aromatic position; compounds with longer alkyl groups and smaller ring-sized compounds at the alkylamine position showed stronger inhibitory activities. Docking simulation conducted for two compounds,

Identifiants

pubmed: 36098044
pii: biomolther.2022.047
doi: 10.4062/biomolther.2022.047
pmc: PMC9810443
doi:

Types de publication

Journal Article

Langues

eng

Pagination

108-115

Références

J Neurochem. 2004 Oct;91(2):362-73
pubmed: 15447669
Eur J Pharmacol. 2013 Jan 30;700(1-3):147-51
pubmed: 23261499
Mol Pharmacol. 2001 Dec;60(6):1181-8
pubmed: 11723224
Addict Sci Clin Pract. 2015 Mar 25;10:8
pubmed: 25928069
J Neurochem. 1991 Jan;56(1):213-20
pubmed: 1670953
Int J Mol Sci. 2020 Dec 17;21(24):
pubmed: 33348640
J Neurochem. 1990 Dec;55(6):1827-37
pubmed: 2172461
J Biol Chem. 1993 Jan 5;268(1):337-41
pubmed: 8380158
Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):8966-71
pubmed: 11459929
Cell Signal. 2009 Jan;21(1):87-94
pubmed: 18929645
Neuroimage Clin. 2018 Mar 18;18:770-783
pubmed: 29845013
Behav Neurosci. 2006 Aug;120(4):888-904
pubmed: 16893295
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Brain Res. 1986 Jun;396(2):157-98
pubmed: 3527341
J Neurochem. 1993 Aug;61(2):764-7
pubmed: 8336153
Neurochem Int. 2014 Jul;73:27-31
pubmed: 24161617
Neuron. 2001 Apr;30(1):121-34
pubmed: 11343649
Nature. 2015 May 21;521(7552):322-7
pubmed: 25970245
PLoS One. 2016 May 12;11(5):e0155183
pubmed: 27171006
Neurochem Res. 1987 Feb;12(2):173-8
pubmed: 2437473
J Comput Chem. 2007 Apr 30;28(6):1145-52
pubmed: 17274016
Proc Natl Acad Sci U S A. 1996 May 14;93(10):5166-71
pubmed: 8643547
Biomol Ther (Seoul). 2017 Jan 1;25(1):26-43
pubmed: 28035080
J Neurochem. 2011 Jan;116(2):164-76
pubmed: 21073468
Nature. 1996 Feb 15;379(6566):606-12
pubmed: 8628395
J Chem Inf Model. 2013 Aug 26;53(8):1893-904
pubmed: 23379370
J Neurochem. 1999 Jan;72(1):148-56
pubmed: 9886065
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
Pharmacol Rev. 1999 Sep;51(3):439-64
pubmed: 10471414
Bioanalysis. 2010 May;2(5):965-79
pubmed: 21083227
Bioorg Med Chem Lett. 2003 Feb 10;13(3):513-7
pubmed: 12565962
Science. 1991 Oct 25;254(5031):576-8
pubmed: 1948034
J Biol Chem. 2001 Oct 5;276(40):37409-14
pubmed: 11473130
J Med Toxicol. 2013 Jun;9(2):172-8
pubmed: 23494844
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
Am J Psychiatry. 1973 Jan;130(1):61-7
pubmed: 4345465
Drug Alcohol Depend. 2013 May 1;129(3):167-79
pubmed: 23273775
Science. 1991 Oct 25;254(5031):578-9
pubmed: 1948035
Biol Psychiatry. 2005 Jun 1;57(11):1397-409
pubmed: 15950014
J Med Chem. 1999 Jul 29;42(15):2721-36
pubmed: 10425082
J Pharmacol Exp Ther. 2008 May;325(2):617-28
pubmed: 18182557
Mol Endocrinol. 2010 Mar;24(3):574-86
pubmed: 20160122
Eur J Pharmacol. 1998 May 22;349(2-3):163-9
pubmed: 9671094

Auteurs

Dooti Kundu (D)

College of Pharmacy, Chonnam National University, Gwangju 61146, Republic of Korea.

Anlin Zhu (A)

College of Pharmacy, Chonnam National University, Gwangju 61146, Republic of Korea.

Eunae Kim (E)

College of Pharmacy, Chosun University, Gwangju 61452, Republic of Korea.

Suresh Paudel (S)

College of Pharmacy, Chonnam National University, Gwangju 61146, Republic of Korea.

Choon-Gon Jang (CG)

College of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.

Yong Sup Lee (YS)

College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea.

Kyeong-Man Kim (KM)

College of Pharmacy, Chonnam National University, Gwangju 61146, Republic of Korea.

Classifications MeSH